Joyeeta Roy

7PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsToxicology (incl. clinical toxicology)Cancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 16, 2026
Copper Transporter 1‑Mediated Deregulation of Copper Homeostasis Impacts MYC and Oxidative Phosphorylation Pathways and Increases the Sensitivity of Tumor Cells to Complex I Inhibitors.

|Jan 10, 2026
An Update on Clinically Advanced PROTAC Degraders and Their Synthesis.

Ranjan Kumar Acharyya, Yugandhar Kothapalli, Suresh Yarlagadda

|Apr 17, 2025
PSP205, a Novel Phenyl Sulfonyl Piperidine, Induces Apoptotic Cell Death in Colon Cancer by Modulating Coat Protein Complex-Mediated Vesicle Trafficking.

Soma Samanta, Joyeeta Roy, Bikash Debnath

|Mar 26, 2025
Copper-KRAS-COX2 Axis: A Therapeutic Vulnerability in Pancreatic Cancer.

Joyeeta Roy, Rima Mouawad, Armita Kyani

|Apr 27, 2024
Orally Bioavailable Proteolysis-Targeting Chimeras: An Innovative Approach in the Golden Era of Discovering Small-Molecule Cancer Drugs.

Rohan Kalyan Rej, Srinivasa Rao Allu, Joyeeta Roy

|Aug 17, 2023
First-in-Class NADH/Ubiquinone Oxidoreductase Core Subunit S7 (NDUFS7) Antagonist for the Treatment of Pancreatic Cancer.

Yibin Xu, Ding Xue, Armita Kyani

Pageof 2

Frequent Collaborators

5 joint publications

Nouri Neamati

3 joint publications

Yibin Xu

2 joint publications

Maha Hanafi

2 joint publications

Duxin Sun